We are delighted to extend our heartfelt gratitude to all participants of the International Alzheimer’s Disease & Dementia Conference (Dementia 2022), which was virtually hosted by Magnus Group on June 15-16, 2022. The conference, centered around the theme “Explicating Advancements to Combat the Silent Epidemic of Dementia and Alzheimer,” was a resounding success. Together, we presented hope through fresh research, information, and innovative treatments related to Alzheimer’s and dementia. Thank you for your valuable contributions and for making Dementia 2022 a memorable and impactful event.
Important Alert:
X
Title : Can we stimulate neuroplasticity with the cell signaling molecule ghrelin?
Irina Stoyanova, Medical University of Varna, Bulgaria
Title : Sleep quality improvement for Alzheimer’s disease
Benyi Li, University of Kansas, United States
Title : Breakthrough in Dementia
Esther Ebenezer, UniKL Royal College of Medicine Perak, Malaysia
Title : Implications for Serum Amyloid P in the Pathogenesis of Alzheimer’s Disease
Mark S Kindy, University of South Florida and the James A. Haley VA Hospital, United States
Title : Memory decline in dementia and its impact on spoken spontaneous discourse production
Anthony Pak-Hin Kong, The University of Hong Kong, Hong Kong
Title : Brain insulin resistance in Alzheimer’s disease: can phytochemicals exert beneficial effects?
Mario Allegra, University of Palermo, Italy